Product Information
CORTISPORIN-TC EAR SUSPENSION is a brand product labeled by Endo USA Inc., priced at $21.9810 per ML under NDC 63481052910. Its NADAC has been published 346 times since Aug 21, 2019.
FDA first approved this application before 1982.
CORTISPORIN-TC EAR SUSPENSION
colistin sulfate, neomycin sulfate, thonzonium bromide and hydrocortisone acetateStrength
3; 10; 3.3; .5 mg/mL; mg/mL; mg/mL; mg/mL
Manufacturer
Endo USA Inc.NDC
63481052910
Classification
Brand
Dosage Form
SUSPENSION
Route
AURICULAR (OTIC)
Effective Date
9/23/2026
Approval Type
New Drug (NDA)
FDA Application
NDA050356FDA Approved
Before 1982
On Market Since
6/3/2019
Pharmacological Classes
Price Statistics
The NADAC for CORTISPORIN-TC EAR SUSPENSION has been published 346 times since Aug 21, 2019, and over the history we have for it it has declined 2.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.9810 per ML |
|---|---|
| All-time high | $22.4337 (Oct 16, 2019) |
| All-time low | $21.9647 (Jan 22, 2025) |
| 52-week high | $22.0695 |
| 52-week low | $21.9810 |
| Median price | $22.1235 |
| Average price | $22.1466 |
| Largest weekly change | -1.6% (Oct 23, 2019) |
| Weeks tracked | 346 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the colistin sulfate, neomycin sulfate, thonzonium bromide and hydrocortisone acetate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Endo USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
colistin sulfate, neomycin sulfate, thonzonium bromide and hydrocortisone acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CORTISPORIN-TC EAR SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for CORTISPORIN-TC EAR SUSPENSION, manufactured by Endo USA Inc., is $21.9810 per ML (NDC 63481052910), effective Sep 30, 2026.
How has the price of CORTISPORIN-TC EAR SUSPENSION changed over time?
Over the history we have for it, the NADAC for CORTISPORIN-TC EAR SUSPENSION has declined 2.0%. It has been tracked across 346 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for CORTISPORIN-TC EAR SUSPENSION?
Since Aug 21, 2019, the NADAC for CORTISPORIN-TC EAR SUSPENSION has ranged from a low of $21.9647 (Jan 22, 2025) to a high of $22.4337 (Oct 16, 2019), with a median of $22.1235 per ML.
Are there cheaper alternatives to CORTISPORIN-TC EAR SUSPENSION?
No other NADAC-published product currently shares the active ingredient and strength of CORTISPORIN-TC EAR SUSPENSION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CORTISPORIN-TC EAR SUSPENSION?
CORTISPORIN-TC EAR SUSPENSION (NDC 63481052910) is labeled by Endo USA Inc., and CMS classifies it as a brand product.